Serum angiotensin converting enzyme
Insertion/Deletion Polymorphisms and Serum Angiotensin-converting Enzyme Levels in Iranian Patients with Sarcoidosis
... Serum ACE activity in patients and controls with genotypes separation is described in Table 1. The association between sACE activity in three geno- types of sarcoidosis patients and the control sub- jects was ...
8
The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases
... of serum lysozyme for predicting sarcoidosis was reported as ...of serum ACE for predicting sarcoidosis was reported as 59 % ...of serum lysozyme level has been reported to be less for sarcoidosis ...
9
Autoantibodies to angiotensin converting enzyme 2 in patients with connective tissue diseases
... tensin-converting enzyme 2 autoantibodies and activity in vas- culopathy ...of serum angiotensin- converting enzyme (ACE) 2 compared with the reference value and ELISA score of ...
8
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis
... examining angiotensin-converting enzyme levels, pulmonary function data, and angiotensin-converting enzyme inhibitor ...RESULTS. Serum angiotensin-converting ...
11
The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease
... sandwich enzyme-linked immuno- sorbent assay (R&D Systems, Abingdon, UK) was used ac- cording to the manufacturer’ s guidelines to measure the ACE concentration in CSF and serum, as described previ- ...
10
An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels
... in serum ACE levels was observed between subjects in each of the three ACE genotype ...classes. Serum immunoreactive ACE concentrations were, respectively, ...
5
Original Article Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism is associated with dry eye syndrome (DES) in Korean population
... Since angiotensin converting enzy- me is crucial for formation of Ang II encoded by the ACE gene, there have been many studies on variation of the ACE ...increased serum ACE activity and risk for ...
7
Evaluation of G2350A Polymorphism of the Angiotensin-Converting Enzyme (ACE) Gene in Chronic Kidney Disease
... (FBS), Serum creatinine, eGFR, triglyceride (TG), serum total cholesterol (TCH), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) (p < ...
5
Journal homepage: www.ijptjournal.com A PROSPECTIVE OBSERVATIONAL STUDY ON MANAGEMENT OF HYPERTENSION IN PATIENTS ON HEMODIALYSIS
... Hypertension). Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers may decrease morbidity and mortality (Sarah S et ...in serum potassium (particularly ...
5
Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis
... test, angiotensin converting enzyme inhibitor or angiotensin receptor blocker [ACE/ARB] prescription, and several tests monitoring for complications) and intermediate clinical outcomes (mean ...
8
EFFECT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ON SERUM AMYLASE AND LIPASE IN PATIENTS WITH HYPERTENSION
... Introduction: Angiotensin-converting enzyme (ACE) inhibitors are a class of potential drugs used as first-line agents for the treatment of hypertension and heart failure in physiologically young ...
5
Original Article Meta-analysis of the association between angiotensin-converting enzyme I/D polymorphism and chronic obstructive pulmonary disease risk
... the angiotensin-converting enzyme (ACE) gene accounts for most of the variability of serum ACE activity and is associated with the development of chronic obstructive pulmonary disease ...
6
Impact of I/D polymorphism of angiotensin converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients
... not angiotensin II plasma levels [34, ...in angiotensin II production, not ACE ...that angiotensin II can affect vascular smooth muscle growth in cell culture [37], however, only hyper- plasia is ...
6
Insertion/Deletion Gene Polymorphism and Serum Level of Angiotensin Converting Enzyme
... Our results demonstrated that the DD genotype was associated with higher plasma ACE concentration in Iranians. In addition, our data suggested that the allele of I is more frequent than D in Iranian people. We also found ...
5
Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients
... This study showed that 39.1 % of the patients who measured serum potassium level developed hyperkalemia. It is reported that hyperkalemia has been attributed to the use of ACE inhibitors in 10 to 38 percent of ...
5
Renal and Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitor Plus Angiotensin II Receptor Antagonist Therapy in Children With Proteinuria
... and serum potassium levels remained constant throughout the entire study, showing that the chosen drugs at the dosages used, both alone and in combination, did not produce adverse effects on renal function and ...
8
Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide
... In the present study, the mechanism of RLP in lower- ing blood pressure was further identified. The ET and Ang II levels in plasma, kidneys and hearts of the RLP- treated SHRs dramatically decreased compared with that of ...
9
Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review
... of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in heart fail- ure patients with type 2 diabetes mellitus (Table ...
5
“A Class Review on ACE Inhibitors/ARBS and Beta Blockers and Effectiveness in HFrEF” by Rakhi K R, Dhandapani Chidambaram, Aleena Alex, Ann Merry Davis, Bharathi K, Keerthanaa B, India.
... Heart failure with reduced ejection fraction is mainly develops as a consequence of long existing cardiovascular disease, Hypertension, coronary artery disease etc. Apart from the usual pathophysiology of heart failure, ...
5
<p>Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan</p>
... elevated serum creatinine ( ≥ ...elevated serum creatinine or 2) >50% reduction in glomerular fi ltration rate, over a mean follow-up time of 51 ...
11